These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3602064)

  • 1. [Determination and interpretation of in vitro solubility behavior of pharmaceutical agents. 2. The effect of surface tension of the dissolution medium on the liberation of drugs in commercial preparations (tablets, dragees)].
    Bornschein M; Eitz K; Voigt R
    Pharmazie; 1987 Feb; 42(2):83-6. PubMed ID: 3602064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The determination and interpretation of in-vitro dissolution behavior of pharmaceutical substances. 1. Powders, mixtures and granules].
    Voigt R; Eitz K; Bornschein M
    Pharmazie; 1987 Jan; 42(1):22-5. PubMed ID: 3575398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Testing of drug release from film pellets with special consideration of the thickness of the polymer coating].
    Voigt R; Wunsch G
    Pharmazie; 1986 Feb; 41(2):114-7. PubMed ID: 3725849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug liberation from floating capsules in the rotating-flask solubility tester].
    Koch HP; Mertz M; Zinterhof G
    Pharmazie; 1987 May; 42(5):312-5. PubMed ID: 3671440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diclofenac sodium multisource prolonged release tablets--a comparative study on the dissolution profiles.
    Bertocchi P; Antoniella E; Valvo L; Alimonti S; Memoli A
    J Pharm Biomed Anal; 2005 Apr; 37(4):679-85. PubMed ID: 15797788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on dissolution in vitro of Zhike Pingchuan sustained-release tablets].
    Li X; Feng Z; Huo W; Li Y; Wang B; Zhu S
    Zhongguo Zhong Yao Za Zhi; 2009 May; 34(10):1216-9. PubMed ID: 19673379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of polysorbates on drug release from wax matrices.
    Dredán J; Zelkó R; Bihari E; Rácz I; Gondár E
    Drug Dev Ind Pharm; 1998 Jun; 24(6):573-6. PubMed ID: 9876626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro dissolution profile of water-insoluble drug dosage forms in the presence of surfactants.
    Shah VP; Konecny JJ; Everett RL; McCullough B; Noorizadeh AC; Skelly JP
    Pharm Res; 1989 Jul; 6(7):612-8. PubMed ID: 2798311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of different variables on the in vitro dissolution of a theophylline sustained-release preparation].
    Fuchs WS; Jakobs R; Grunenberg P; Weiss G; Profitlich T; von Nieciecki A; Klemm FH; Laicher A; Stanislaus F
    Arzneimittelforschung; 1998 May; 48(5A):552-6. PubMed ID: 9676343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved drug dissolution and product characterization using a crescent-shaped spindle.
    Qureshi SA
    J Pharm Pharmacol; 2004 Sep; 56(9):1135-41. PubMed ID: 15324482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of dissolution tests for fexofenadine hydrochloride capsules and coated tablets.
    Breier AR; Paim CS; Steppe M; Schapoval EE
    J Pharm Pharm Sci; 2005 Aug; 8(2):289-98. PubMed ID: 16124939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro dissolution test of tamoxifen citrate preparations.
    Braga RM; Carvalho RD; Fonseca SG; Strattmann R; De Santana DP; De Albuquerque MM
    Boll Chim Farm; 2001; 140(6):467-70. PubMed ID: 11822241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of surfactants of Rofam type on properties of piroxicam tablets.
    Szulc-Musioł B; Jankowski A
    Acta Pol Pharm; 2009; 66(2):195-200. PubMed ID: 19719055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrepancy among dissolution rates of commercial tablets as a function of dissolution method. part 6: rifampicin.
    Ammar HO; Khalil RM
    Pharmazie; 1996 Mar; 51(3):165-8. PubMed ID: 8900866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors effecting drug release from inert matrices. Part 1: effects of surfactants on the release of quinine sulfate.
    Choulis NH; Papadopoulos H
    Pharmazie; 1975 Apr; 30(4):233-6. PubMed ID: 239411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of drug dissolution from tablets and capsules at high saturation.
    Kallay N; Senjković R
    Pharm Acta Helv; 1987; 62(12):337-40. PubMed ID: 3441479
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative in vitro studies of allopurinol in commercial preparations].
    Georgarakis M; Iconomout N
    Pharmazie; 1984 Apr; 39(4):248-50. PubMed ID: 6739528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of dissolution media composition on drug release and in-vitro/in-vivo correlation for paracetamol matrix tablets prepared with novel carbomer polymers.
    Parojcić J; Ethurić Z; Jovanović M; Ibrić S; Jovanović D
    J Pharm Pharmacol; 2004 Jun; 56(6):735-41. PubMed ID: 15231038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the USP dissolution test method A for enteric-coated articles by planar laser-induced fluorescence.
    Miller DA; Gamba M; Sauer D; Purvis TP; Clemens NT; Williams RO
    Int J Pharm; 2007 Feb; 330(1-2):61-72. PubMed ID: 17034967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.